CN108355106B

CN108355106B - Traditional Chinese medicine formula for ventilating lung and abating fever

Info

Publication number: CN108355106B
Application number: CN201810211552.5A
Authority: CN
Inventors: 李新民
Original assignee: FIRST AFFILIATED HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Current assignee: FIRST AFFILIATED HOSPITAL OF TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Priority date: 2018-03-14
Filing date: 2018-03-14
Publication date: 2021-02-05
Anticipated expiration: 2038-03-14
Also published as: CN108355106A

Abstract

The invention provides a traditional Chinese medicine formula for ventilating lung and allaying fever, which is characterized in that: the traditional Chinese medicine composition comprises, by weight, 3-13 parts of honeysuckle, 1-8 parts of ephedra, 3-13 parts of almond, 12-27 parts of gypsum, 3-13 parts of fructus forsythiae, 3-13 parts of radix curcumae, 3-13 parts of stiff silkworm, 3-13 parts of radix bupleuri, 3-13 parts of radix puerariae and 2-7 parts of liquorice. The traditional Chinese medicine formula disclosed by the invention has the advantages that the compatibility of the traditional Chinese medicine accords with the principle of monarch, minister, assistant and guide of the traditional Chinese medicine, the number of the medicines is small, the pure traditional Chinese medicine is adopted for treating the infantile pneumonia, the traditional Chinese medicine has a good clinical curative effect, no toxic or side effect exists, the use of antibiotics for infants with pneumonia can be obviously reduced, and the toxic or side effect of western antibacterial medicines is avoided.

Description

Traditional Chinese medicine formula for ventilating lung and abating fever

Technical Field

The invention belongs to the technical field of traditional Chinese medicine formulas, and particularly relates to a traditional Chinese medicine formula for ventilating the lung and reducing fever.

Background

Pneumonia is one of common respiratory diseases of children, is also the most common cause of hospitalization of children, and is the leading cause of death of children under the age of 5 years old. Infantile pneumonia can occur all the year round, but is common in alternate seasons and seasons, and mainly has symptoms of fever, cough, dyspnea, chest wall air-absorbing depression and fixed moist rale of lung, and serious cases can involve nerves, circulation and digestive system to cause corresponding diseases. The children pneumonia is caused by various pathogens, bacteria, viruses, mycoplasma, chlamydia and the like are common, the treatment mainly comprises the application of antibiotics and western antiviral drugs, the application of the antibiotics is unreasonable and standard at present, the pathogenic bacteria resistance rate is obviously increased, the western antiviral drugs with definite curative effects are fewer, the specificity is lacked, and meanwhile the western antibacterial drugs have certain toxic and side effects.

Disclosure of Invention

In view of the above, the invention aims to provide a traditional Chinese medicine formula for ventilating the lung and reducing fever, which overcomes the defects of the prior art, has obvious curative effect and little side effect, and can supplement western medicines.

In order to achieve the purpose, the technical scheme of the invention is realized as follows:

a traditional Chinese medicine formula for dispersing lung qi and reducing fever comprises, by weight, 3-13 parts of honeysuckle, 1-8 parts of ephedra, 3-13 parts of almond, 12-27 parts of gypsum, 3-13 parts of fructus forsythiae, 3-13 parts of radix curcumae, 3-13 parts of stiff silkworm, 3-13 parts of radix bupleuri, 3-13 parts of radix puerariae and 2-7 parts of liquorice.

Preferably, the traditional Chinese medicine composition comprises, by weight, 6-10 parts of honeysuckle, 3-6 parts of ephedra, 6-10 parts of almond, 15-25 parts of gypsum, 6-10 parts of fructus forsythiae, 6-10 parts of radix curcumae, 6-10 parts of stiff silkworm, 6-10 parts of radix bupleuri, 6-10 parts of radix puerariae and 3-6 parts of liquorice.

Preferably, the traditional Chinese medicine composition comprises, by weight, 8 parts of honeysuckle, 4 parts of ephedra, 8 parts of almond, 20 parts of gypsum, 8 parts of fructus forsythiae, 8 parts of radix curcumae, 8 parts of stiff silkworm, 8 parts of radix bupleuri, 8 parts of radix puerariae and 5 parts of liquorice.

The invention also provides a method for preparing the traditional Chinese medicine formula for ventilating the lung and reducing fever, which comprises the following steps,

(1) putting the components into a decocting container;

(2) adding water in an amount which is 5-8 times of the weight of the non-mineral medicines, and soaking for 20-40 min;

(3) boiling with strong fire, decocting with slow fire for 30 min, filtering with filter screen with pore diameter less than 0.5mm, and collecting filtrate.

The invention also provides application of the lung ventilating and fever abating traditional Chinese medicine formula in medicines for treating infantile pneumonia or bronchitis.

Honeysuckle flower, flos Lonicerae, sweet in nature and cold in nature, is fragrant, sweet in nature and cold in nature, clears heat without hurting stomach, and is fragrant and capable of eliminating pathogenic factors. The honeysuckle can disperse wind-heat and clear away blood toxin, and has obvious effect on various heat diseases such as fever, eruption, macula, sore and carbuncle due to heat toxin, sore throat and the like. The honeysuckle contains chlorogenic acid, luteolin glycoside and other pharmacological active ingredients, and has strong inhibitory effect on hemolytic streptococcus, staphylococcus aureus and other pathogenic bacteria, upper respiratory infection pathogenic viruses and the like.

Ma Huang is pungent, slightly bitter and warm. It enters lung and bladder meridians. Induce sweating and dispel cold, ventilate lung and relieve dyspnea, induce diuresis to alleviate edema.

Almond, sweet and bitter in taste, has the actions of relieving cough and asthma and relaxing bowel, and can be used for treating diseases such as lung disease and cough.

Gypsum, Gypsum Fibrosum, is indicated for apoplexy with chills and fever, and has the functions of relieving muscles and sweating, removing dry mouth and tongue, headache and toothache, etc. Among them, sulfur and oxygen contained in the herb can be dissipated by cooling, and has the action of expelling pathogenic factors from the exterior and muscles, and the external sensation of excess heat.

Fructus forsythiae has effects in clearing away heat and toxic materials, relieving swelling, dispersing pathogen accumulation, relieving inflammation, inhibiting bacteria, and inhibiting viruses.

Radix Curcumae, pungent and bitter with the action of cooling, enters heart, lung and liver meridians, and has the effects of promoting qi circulation, relieving depression, cooling blood and removing blood stasis.

Bombyx Batryticatus has the effects of dispelling pathogenic wind, relieving spasm, dissipating phlegm and resolving masses, and is clinically used for treating tangible masses such as nodules, sore throat, scrofula, urticaria of wind sores and the like.

Radix bupleuri, being bitter and pungent in flavor and slightly cold in nature, enters liver and gallbladder meridians and has the effects of relieving exterior syndrome, relieving fever, soothing liver, relieving depression and lifting yang qi. Pharmacological research shows that the main component of bupleurum contains saikoside, and then contains phytosterol, adonitol, and a small amount of volatile oil and polysaccharide; the aerial parts mainly contain flavonoid, small amount of saponins, coumarins, lignans, etc. Has antibacterial, antiinflammatory, antiviral, antipyretic, immunity regulating, antitumor, blood lipid reducing, and liver protecting effects. Bupleurum root, radix bupleuri can strengthen the actions of relieving exterior syndrome, relieving fever, and lifting the qi of spleen and stomach to clear yang.

Kudzu root, sweet, pungent and cool. Has the functions of expelling pathogenic factors from muscles, allaying fever, promoting eruption, promoting the production of body fluid to quench thirst, invigorating yang and stopping diarrhea.

Licorice root, radix Glycyrrhizae is sweet in flavor and neutral in nature, and enters heart, lung, spleen and stomach meridians.

The pharmacological analysis of the invention: in the recipe, Ma Huang is lung-ventilating to disperse the cold on the exterior; the almond kernel is supplemented with the ephedra to ventilate the lung and play the role of lowering adverse qi to relieve cough; gypsum Fibrosum has effects of clearing lung-heat and clearing heat in the interior; the honeysuckle and the weeping forsythia disperse wind-heat, clear away heat and toxic material, avoid dirt and remove turbid; radix Curcumae and Bombyx Batryticatus have effects of promoting blood circulation, dispelling blood stasis, promoting qi circulation, and dredging collaterals; radix bupleuri and radix puerariae have the effects of relieving muscles and clearing heat; the liquorice can regulate the medicine property and also can help gypsum to promote the production of body fluid. The whole formula has the effects of freeing lung, clearing heat, removing blood stasis and dredging collaterals.

The invention is mainly used for treating diseases, such as infantile pneumonia or bronchitis, with symptoms of fever, cough, expectoration, red throat, red tongue, thin and yellow or yellow fur, rapid pulse and loose stool.

Compared with the prior art, the lung ventilating and fever abating traditional Chinese medicine formula disclosed by the invention has the following advantages:

the traditional Chinese medicine formula disclosed by the invention has the advantages that the compatibility of the traditional Chinese medicine accords with the principle of monarch, minister, assistant and guide of the traditional Chinese medicine, the number of the medicines is small, the pure traditional Chinese medicine is adopted for treating the infantile pneumonia, the traditional Chinese medicine has a good clinical curative effect, no toxic or side effect exists, the use of antibiotics for infants with pneumonia can be obviously reduced, and the toxic or side effect of western antibacterial medicines is avoided.

Drawings

FIG. 1 is a comparison of time to complete annealing KM curve.

Detailed Description

Unless defined otherwise, technical terms used in the following examples have the same meanings as commonly understood by one of ordinary skill in the art to which the present invention belongs. The test reagents used in the following examples, unless otherwise specified, are all conventional biochemical reagents; the experimental methods are conventional methods unless otherwise specified.

The present invention will be described in detail with reference to examples.

The traditional Chinese medicine formula for dispersing lung qi and bringing down fever used in the following treatment groups comprises, by weight, 8 parts of honeysuckle, 4 parts of ephedra, 8 parts of almond, 20 parts of gypsum, 8 parts of fructus forsythiae, 8 parts of radix curcumae, 8 parts of stiff silkworm, 8 parts of radix bupleuri, 8 parts of radix puerariae and 5 parts of liquorice. 1 part is 1 g.

450 children with bronchopneumonia wind-heat lung block syndrome in a pediatric ward of a first subsidiary hospital of Tianjin Chinese medicine university from 2016 to 2017 are collected. Random number tables were generated using SAS 9.1.3 and divided into 36 treatment groups and 35 control groups.

The treatment groups were 16 men and 20 women; 9 cases aged 0-1, 15 cases aged 1+ -2, 12 cases aged 2+ -3; the fever course before admission is less than or equal to 24h 14 cases and 24+ to 48h 22 cases;

control group 17 men and 18 women; 9 cases aged 0-1, 14 cases aged 1+ -2, 12 cases aged 2+ -3; the fever course before admission is less than or equal to 24h 16 cases and 24+ to 48h 19 cases. The general data comparison of two groups of patients has no statistical significance (P is more than 0.05) and is comparable.

1. Diagnostic criteria

1.1.1 Western diagnostic standards for pediatric bronchopneumonia

Reference is made to the scheme for preventing and treating four diseases in children, the scheme for preventing and treating pneumonia in children, and the 7 th edition of the Utility of Chinese flowering crabapple of China.

(1) General symptoms: the acute or delayed onset of the disease can be accompanied by symptoms such as fever, food refusal, emesis, lethargy, dysphoria, asthma, etc.

(2) Symptoms and signs of the respiratory system: cough and throat sputum, rapid respiration, frequent dyspnea, groan on expiration, nasal flaring, trismus, perioral or nail cyanosis. The early signs of the chest can be unobvious, then middle and coarse humors can be heard, and after several days, fine humors or twitch sounds can be heard; or tubular breath sounds can be heard.

(3) Chest radiography: it can be expressed as nonspecific small-spot sheet-like lung parenchyma infiltration shadow, and the two lungs have more lower wild, heart diaphragm corner area and middle and inner zone, and can be partially fused into large-sheet-like infiltration shadow.

(4) Blood picture: white blood cell count can be reduced, normal or slightly increased.

1.1.2 Chinese medicine diagnosis of pneumonia, dyspnea and cough

(1) Disease diagnosis

According to the diagnosis basis of pneumonia, asthma and cough in the 'standard of curative effect for diagnosing pediatric diseases of traditional Chinese medicine' of the State administration of traditional Chinese medicine.

a. Acute onset with fever, cough, shortness of breath, nasal flaring, wheezy phlegm, etc., or mild cyanosis.

b. In severe cases, dyspnea with restlessness, pale complexion, cyanosis with aggravation, or persistent hyperpyrexia.

c. The infant is usually suffered from congenital deficiency and the course of disease is prolonged.

d. Auscultation of lung, middle and thin moist rales, often accompanied by rales or tubular breath sounds.

e. Blood picture: white blood cell counts may be reduced, slightly increased or normal.

f. Chest radiography: the lung shows increased texture, disorder, and reduced transparency, or is in the form of small, spotted, fuzzy shadows, or uneven large shadows.

(2) Syndrome diagnosis

According to the wind-heat lung-blocking syndrome classification standard of pneumonia, asthma and cough in the national traditional Chinese medicine administration 'Standard of curative Effect for diagnosis of disease of traditional Chinese medicine, Standard of curative Effect for diagnosis of pediatric disease of traditional Chinese medicine'.

Pattern of wind-heat blocking the lung: fever with aversion to wind, slight sweating, thirst with desire for water, cough, thick and yellow sputum, shortness of breath and red throat. A red tongue tip, thin and yellow coating and a superficial and rapid pulse.

1.1.3 Chinese medicine syndrome scoring standard

Refer to the national institute of traditional Chinese medicine "guidelines for clinical research of new drugs".

1.2 inclusion criteria

(1) According with the diagnosis standard, the lung blockage syndrome caused by wind heat of bronchopneumonia is confirmed;

(2) the course of pneumonia does not exceed 48 hours;

(3) the maximum body temperature is more than or equal to 38.5 ℃ within 24 hours before the group is added;

(4) the age is 3-6 years old; the weight is more than or equal to 14 kg;

(5) the number of white blood cells is less than or equal to 10 multiplied by 109/L, and the proportion of neutral granulocytes is less than 70 percent;

(6) c-reactive protein: normal;

(7) hospitalized patients;

(8) the legal guardian of the sick child gives informed consent and signs an informed consent form;

1.3 criteria for excluded cases

(1) When the medicine is selected, patients with heart failure, respiratory failure, toxic encephalopathy, exudative pleurisy and other complications are present.

(2) Bacterial infections were specifically combined at enrollment.

(3) When the selection is performed, serious primary diseases such as heart, liver, kidney and hematopoietic system and the like are combined.

(4) At the discretion of the investigator, there are other lesions that reduce the likelihood of or complicate enrollment.

(5) The infant patient is unable to collaborate or is participating in clinical trials with other medications.

(6) Allergic constitution (allergic to more than two kinds of substances) or allergic to known components of the preparation.

(7) According to the judgment of doctors, the patients are easy to lose visit.

2 method

2.1 methods of treatment

Both groups of children were administered cefuroxime sodium (West Lixin, 0.75 g/ramus, lot No. m869, Kurarin Schker) 80 mg/(kg. d) to the clinically considered bacterial infected patients according to "guidelines for community-acquired pneumonia" 5, and 5% glucose injection was added for intravenous drip 2 times a day; or intravenous drip of ceftriaxone (Rogofen, 1 g/tube, batch number: SH1612, Shanghai Roche pharmaceutical Co., Ltd.) 80 mg/(kg. d), adding 5% glucose injection, and intravenous drip for 1 time per day. Clinical considerations A mycoplasma infected person was administered azithromycin (Shsumei, 0.5 g/ramus, Perey pharmaceutical Co., Ltd.) in an amount of 10 mg/(kg. d) by intravenous drip with 5% glucose injection 1 time a day for 5 days.

The treatment group is added with the Jinhuang antipyretic prescription, 1 dose per day and is orally taken for 3 times. Both groups were treated for 7 days.

2.2 Observation indicators and methods

2.2.1 therapeutic index

The clinical cure is as follows: firstly, fine wet rale disappears in lung auscultation; secondly, complete defervescence; thirdly, the dyspnea disappears; fourthly, cough and phlegm are reduced to I level and below.

The disease is not cured: those who do not meet the clinical recovery standard.

Note: the evaluation of the cough and phlegm congestion degree I grade is referred to the standard of '2 points in the Chinese medicine syndrome point grading quantitative standard table'.

(2) Complete defervescence time: after taking the medicine, the body temperature returns to normal (less than or equal to 37.2 ℃) and is maintained for more than 24 hours.

(3) Evaluation standard of traditional Chinese medicine syndrome curative effect

And (3) healing: the reduction rate of the syndrome score and (including the tongue pulse score) is more than or equal to 90 percent.

The effect is shown: the syndrome score is more than or equal to 67 percent and the reduction rate is less than 90 percent.

The improvement is as follows: the syndrome score is more than or equal to 33 percent and the reduction rate is less than 67 percent.

And (4) invalidation: syndrome score and reduction rate < 33%.

Note: the syndrome score is equal to fever, cough, phlegm accumulation, dyspnea, secondary symptoms (thirst, dry stool, yellow urine) and tongue coating pulse.

(4) Evaluating the curative effect of single symptom index: the treatment effect of the disease is evaluated according to the single indexes (cough, phlegm accumulation and dyspnea and tachypnea).

And (3) healing: the symptoms disappear after treatment.

The effect is shown: after treatment, the symptoms are graded by 2 grades from severe to mild.

The method has the following advantages: after treatment, the symptoms are graded by 1 grade, namely from severe to moderate, or from moderate to mild.

And (4) invalidation: there was no change before and after treatment.

2.2.2 safety indices two groups of infants were examined for blood routine, urine routine, stool routine, electrocardiogram and liver and kidney function indices before and after treatment.

2.3 Standard of the treatment Effect of TCM syndrome

According to the technical points of clinical research on traditional Chinese medicine in paediatrics diseases, the recovery rate is that the reduction rate of syndrome integral sum (including tongue pulse value) is more than or equal to 90 percent; the obvious effect is that the syndrome integral is more than or equal to 70 percent and the reduction rate is less than 90 percent; effective, the integral of the syndrome is more than or equal to 30 percent, and the reduction rate is less than 70 percent; the failure rate of the syndrome integration and reduction rate is less than 30 percent. The cure rate is (number of cure cases + number of significant cases + number of effective cases)/total number of cases × 100%.

2.4 statistical methods

SPSS 17.0 statistical software was used. Qualitative data is described in terms of frequency tables, percentages or composition ratios; quantitative data are described as mean ± standard deviation. Adopting X2 test for qualitative data; quantitative data were tested using a t-test, and hypothesis testing was performed using a two-sided test in unison.

3 results

3.1 test control group infant basic data

The demographic data (sex, ethnicity, age, height, weight), pneumonia course, etc. of the subjects before treatment are compared among groups, and the differences have no significant meaning (P is more than 0.05) and are comparable.

TABLE 1 comparison of basic data of children patients

3.2 baseline data for disease symptoms in control group of infants

The related indexes of the curative effect comprise the sum of the main symptoms, the traditional Chinese medicine syndrome score and the scores of single symptoms (fever, cough, dyspnea, phlegm congestion and the like), and the comparative difference among the indexes has no significant statistical significance (P is more than 0.05), and has comparability (shown in a table 2).

TABLE 2 comparison of disease symptom data of children patients

3.2 results of the study

3.2.1 comparison of therapeutic efficacy of diseases

3.2.1.1 comparison of efficacy of disease treatment in control group on day 7 of treatment and at the end of treatment

On day 7 of treatment, the treatment group had a recovery rate (recovery + significant) of 41.67% and the control group was 17.14% (table 3); the treatment group showed 80.56% more significant and 45.71% more significant at the end of treatment (table 4). The analysis results of the curative effect grade and the healing rate on the 7 th day of treatment and at the end of treatment show that the two groups of differences have significant statistical significance (P is less than 0.05), and the curative effect of the disease in the treatment group is better than that in the control group in combination with clinic.

TABLE 3 therapeutic Effect on day 7 disease

TABLE 4 therapeutic effects on diseases at the end of treatment

3.2.2 comparison of the therapeutic effects of the syndromes of traditional Chinese medicine

3.2.2.1 comparison of the curative effects of the TCM syndrome at the 7 th day of treatment and at the end of the treatment in the control group

On the 7 th day of treatment, the treatment group with the rate of the traditional Chinese medicine syndrome curative effect becoming more significant was 50.0%, and the control group was 28.57% (table 5); the treatment group with the rate of the treatment becoming more significant than the treatment effect of the syndrome of traditional Chinese medicine at the end of the treatment was 94.44%, and the control group was 71.43% (table 6). The analysis results of the curative effect grade and the healing rate of 7 days and 10 days after treatment show that the two groups of differences have significant statistical significance (P is less than 0.05), and the curative effect of the syndrome of the treatment group is better than that of the control group in combination with clinic.

TABLE 5 curative effects on syndrome of TCM on day 7

TABLE 6 curative effects of the Chinese medicine syndrome at the end of the treatment

3.2.3 evaluation of the efficacy of Individual symptoms

3.2.3.1 comparison of the rate of increasing fever

At the end of treatment, all children with fever symptoms are cured clinically (fever symptoms disappear), so that the improvement on fever symptoms is realized, and no significant difference exists between a treatment group and a control group. (Table 7)

TABLE 7 comparison of the heat generation increasing rates

3.2.3.2 comparison of the prevalence of cough

The curative rate of cough symptom curative effect of the 2 groups is 72.22% of the treatment group and 40.0% of the control group respectively, the difference of the two groups has significance statistical significance (P is less than 0.05), and the curative effect of cough symptom curative effect of the treatment group is better than that of the control group. (Table 8)

TABLE 8 comparison of the rate of progression of cough

3.2.3.3 comparison of the rate of increasing phlegm accumulation

The curative effect of the phlegm obstruction symptoms of the 2 groups is respectively 75.0 percent of that of the treatment group and 31.43 percent of that of the control group, the difference of the two groups has significant statistical significance (P is less than 0.05), and the curative effect of the phlegm obstruction symptoms of the treatment group is better than that of the control group. (watch 9)

TABLE 9 comparison of the curative ratio of phlegm accumulation

3.2.3.4 comparison of the incidence of wheezing

Since some of the infants did not show tachypnea at the time of onset, 25 of the 71 infants collected showed tachypnea, and the treatment groups showed no significant difference from the control group in the rate at which the therapeutic effect of the tachypnea became more significant at the end of the treatment. (watch 10)

TABLE 10 comparison of the incidence of dyspnea

3.2.4 comparison of complete antipyretic time of control group

The two groups had complete antipyretic time, median time of the treatment group was 0.5 days, that of the control group was 1.0 day, and the median time of the treatment group was shorter than that of the control group. KM profile of complete antipyretic time for both groups of whole subjects. The Log-Rank test results of the complete antipyretic time of the two groups show that the difference has significant statistical significance (P is less than 0.05). (shown in FIG. 1)

3.2.5 Security analysis

In the treatment process, the two groups of medicines have better compliance, and no adverse event occurs. (watch 11)

TABLE 11 degree of drug administration and adverse events

The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.

Claims

1. A lung ventilating and fever abating traditional Chinese medicine composition for treating infantile pneumonia or bronchitis is characterized in that: the traditional Chinese medicine composition comprises, by weight, 3-13 parts of honeysuckle, 1-8 parts of ephedra, 3-13 parts of almond, 12-27 parts of gypsum, 3-13 parts of fructus forsythiae, 3-13 parts of radix curcumae, 3-13 parts of stiff silkworm, 3-13 parts of radix bupleuri, 3-13 parts of radix puerariae and 2-7 parts of liquorice.

2. The lung ventilating and fever abating traditional Chinese medicine composition for treating infantile pneumonia or bronchitis according to claim 1, which is characterized in that: the traditional Chinese medicine composition comprises, by weight, 6-10 parts of honeysuckle, 3-6 parts of ephedra, 6-10 parts of almond, 15-25 parts of gypsum, 6-10 parts of fructus forsythiae, 6-10 parts of radix curcumae, 6-10 parts of stiff silkworm, 6-10 parts of radix bupleuri, 6-10 parts of radix puerariae and 3-6 parts of liquorice.

3. The lung ventilating and fever abating traditional Chinese medicine composition for treating infantile pneumonia or bronchitis according to claim 1, which is characterized in that: the traditional Chinese medicine composition comprises, by weight, 8 parts of honeysuckle, 4 parts of ephedra, 8 parts of almond, 20 parts of gypsum, 8 parts of fructus forsythiae, 8 parts of radix curcumae, 8 parts of stiff silkworm, 8 parts of radix bupleuri, 8 parts of radix puerariae and 5 parts of liquorice.

4. A method for preparing the lung-ventilating and fever-abating traditional Chinese medicine composition for treating infantile pneumonia or bronchitis according to any one of claims 1 to 3, which is characterized by comprising the following steps: comprises the following steps of (a) carrying out,

(1) putting the components into a decocting container;

5. The application of the lung ventilating and fever abating traditional Chinese medicine composition as claimed in any one of claims 1 to 3 in preparing a medicine for treating infantile pneumonia or bronchitis.